FDI has increased in India's pharmaceutical industry since economic liberalization began in the 1990s. India allows up to 100% FDI in drugs and pharmaceuticals under an automatic route. The pharmaceutical industry attracts foreign investment due to India's skilled labor, established supply chains, and large domestic market. FDI inflows to the pharmaceutical sector have increased substantially, from $48.4 million in 2000 to over $9 billion by 2012, as India offers competitive production costs and the government further opened sectors to foreign investment.
A descriptive research paper about the Foreign Direct Investment (FDI) in the Indian Pharmaceutical Industry.
It is a descriptive study on the history of FDI especially in the Indian Pharmaceutical Industry, as well as providing a SWOT Analysis, as well as information on the current market leaders and investors.
Also, the effect of government policies and recent financial changes are mentioned in the presentation
A descriptive research paper about the Foreign Direct Investment (FDI) in the Indian Pharmaceutical Industry.
It is a descriptive study on the history of FDI especially in the Indian Pharmaceutical Industry, as well as providing a SWOT Analysis, as well as information on the current market leaders and investors.
Also, the effect of government policies and recent financial changes are mentioned in the presentation
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
This project talks about the effect of Economic reforms in poverty reduction, employment generation, and economic growth and overall impacts of these reforms
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
COMPANY ANALYSIS: PATANJALI
In the present scenario, the market of ‘Wellness Industry’ in India is less than 2% as compared to the international market. There are untapped opportunities in the wellness industry because of which the government has given special focus on this sector in the ‘Make in India’ campaign. Active involvement from private and public players can create huge impact and buzz in the global market. The motives are the expansion and spreading the awareness and usability.
Patanjali Ayurveda is maker of ayurvedic consumer products and is one of the fastest growing consumer companies in India. The company was formed by Baba Ramdev in 1997 in collaboration with Acharya Balkrishna (scholar of Ayurveda, Sanskrit and Vedas) to manufacture ayurvedic medicines. Ramdev has focused on Yoga while Balkrishna is spreading and channelizing Ayurvedic products.
The company provides a bunch of products and services which revolves around the consumer needs. Providing them high-quality products at attractive prices is the USP. It has become a household name. The company sources raw materials directly from farmers to cut middlemen cost for increasing profits.
Trends & Opportunities for Indian Pharma is a knowledge paper highlighting the upcoming trends and related opportunities in Indian pharmaceuticals industry
Importance of social media in Pharmaceutical industryActiance, Inc.
Guidelines for the pharmaceutical industry are lacking, Novartis had used Facebook and two popular social networking sites, to influence consumers in spreading the word about Tasigna, a cancer drug. The FDA concluded that Novartis’ act failed to meet regulatory and compliance standards. Specifically, the FDA called out Novartis’ marketing as incomplete and misleading since it failed to communicate any risk information associated with the use of Tasigna.
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
This project talks about the effect of Economic reforms in poverty reduction, employment generation, and economic growth and overall impacts of these reforms
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
COMPANY ANALYSIS: PATANJALI
In the present scenario, the market of ‘Wellness Industry’ in India is less than 2% as compared to the international market. There are untapped opportunities in the wellness industry because of which the government has given special focus on this sector in the ‘Make in India’ campaign. Active involvement from private and public players can create huge impact and buzz in the global market. The motives are the expansion and spreading the awareness and usability.
Patanjali Ayurveda is maker of ayurvedic consumer products and is one of the fastest growing consumer companies in India. The company was formed by Baba Ramdev in 1997 in collaboration with Acharya Balkrishna (scholar of Ayurveda, Sanskrit and Vedas) to manufacture ayurvedic medicines. Ramdev has focused on Yoga while Balkrishna is spreading and channelizing Ayurvedic products.
The company provides a bunch of products and services which revolves around the consumer needs. Providing them high-quality products at attractive prices is the USP. It has become a household name. The company sources raw materials directly from farmers to cut middlemen cost for increasing profits.
Trends & Opportunities for Indian Pharma is a knowledge paper highlighting the upcoming trends and related opportunities in Indian pharmaceuticals industry
Importance of social media in Pharmaceutical industryActiance, Inc.
Guidelines for the pharmaceutical industry are lacking, Novartis had used Facebook and two popular social networking sites, to influence consumers in spreading the word about Tasigna, a cancer drug. The FDA concluded that Novartis’ act failed to meet regulatory and compliance standards. Specifically, the FDA called out Novartis’ marketing as incomplete and misleading since it failed to communicate any risk information associated with the use of Tasigna.
Role of Social media in the Pharmaceutical industry in SingaporeAmritha Siddharth
Copyright (c) 2012 Amritha Chottakurien
All Rights Reserved
This product is protected by copyright and distributed restricting copying, distribution, and decompilation.
Pharmaceutical HVAC (Heating, ventilating, and air conditioning; also heating...Palash Das
This slide is represent the HVAC design,qualification and operational approach. As we know HVAC is important system for maintaining clean room. This presentation is made based on the requirement of Pharmaceutical Industry. All parameter are considered based on the current guidelines aspect.
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Pharmaceutical Industry Financial Analysisjpotts89
This is a presentation that was completed for my Corporate Finance class my senior year with a team of three other students. I did my valuation of Eli Lilly.
The impact of social media on the pharmaceutical sectorPaul Grant
A presentation delivered to an audience of medical information, researchers, and clinical trial colleagues from within the pharmaceutical industry at the DIA Clinical Forum in Basel, 12th October 2011
Supply chain issues in Pharma industryJaimeen Rana
Supply Chain Management in pharmaceutical industry plays a very critical part as availability of the product at right time has to be ensured for unpredictable demand patterns. Issues being faced in this industry and solutions for those problems are mentioned in the presentation.
This presentation was a part of my group project study at M S Ramaiah Institute Of Management, Bangalore. Co-Developed by : Shashank M.A, Prasad E. Prabhu, Binit chouraria, Koushik Basak & Uma Maheshwar Rao (MSRIM Bangalore)
By:-
Aniruddh Tiwari
Linkedin :- http://in.linkedin.com/in/aniruddhtiwari
Performance of Foreign Direct Investment in IndiaRHIMRJ Journal
An attempt is made in this paper to know Foreign Direct Investments (FDI) performance in India in terms of Merger
and Acquisition (M&A), Technology transfer and Research & Development (R&D). Beginning of the sections is done with
FDI policy in India. Initially, India has many restrictive policies but it is favorable after liberalization period to attract FDI in
India. Another section of the Paper discussed performance of M&A in terms of number, volume, country and industry wise,
Technology Transfer with suggested government policy and FDI inflow in R&D from the year 2000-2011(post liberalization
period). At the end of the paper,it has been concluded that growth of FDI Inflows is quite positive in above mentioned area.
Performance of Foreign Direct Investment in IndiaRHIMRJ Journal
An attempt is made in this paper to know Foreign Direct Investments (FDI) performance in India in terms of Merger
and Acquisition (M&A), Technology transfer and Research & Development (R&D). Beginning of the sections is done with
FDI policy in India. Initially, India has many restrictive policies but it is favorable after liberalization period to attract FDI in
India. Another section of the Paper discussed performance of M&A in terms of number, volume, country and industry wise,
Technology Transfer with suggested government policy and FDI inflow in R&D from the year 2000-2011(post liberalization
period). At the end of the paper,it has been concluded that growth of FDI Inflows is quite positive in above mentioned area.
Fdi in india:An analysis on the impact of fdi in india’s retail sectorSubhajit Ray
This presentation aims to briefly discuss the critical aspects of FDI in India, present a case study on the success of reforms in the telecommunications sector, analyze both sides of the arguments currently going on regarding FDI in retail and conclude with suggestive measures on the part of the government which can eliminate the negative effects of allowing FDI in India’s retail sector.
Growth and Development of FDI on Indian EconomyIJMER
India has been attracting substantial of foreign direct investment since last few decades,
highly in services sector, telecommunications, software products, real estate etc. FDI are highly
promoting manufacturing sector of India’s exports & attracting more number of earnings on Foreign
exchange, Institutional Investments, MNCs and speeding up our economic growth through Technology
transfer, Employment generation and improved access to managerial expertise, global capital, product
markets and distribution network. FDI bring out the generation-wise innovation, hidden technology,
spending more on research & development to retain our strength in the globalised competitor
products. Indian economy is going to over track the developed and developing countries. Recently, due
to the recession most of the countries have not able to run their investment as well, but India has been
managed better then developed country without elevated struggling. This paper analyzes the growth
and development of FDI and it discussed the Indian economic growth through FDI. In addition it
explains and showed the various sector-wise FDI performances in India
Fdi and its impact on pharmaceutical industry in india
1. FDI AND ITS IMPACT ON
PHARMACEUTICAL
INDUSTRY IN
INDIA
PRESENTED BY:-
YASHICA JAIN (A008)
SHAGUN AGRAWAL(A001)
1
2. CONTENT
1. Introduction to FDI
2. Importance of FDI
3. FDI in INDIA
4. Factors attracting FDI in India
5. Overview of Indian pharmaceutical industries
6. FDI in Indian pharmaceutical sector
7. Inflow of FDI in Indian pharmaceutical industries.
8. Conclusion
2
3. INTRODUCTION
A Foreign direct investment is an acquisition or construction of
physical capital by a firm from one country in another (host)
country.
Besides providing capital inflow, the FDI can offer foreign
technology, managerial skills and improvement of the
international competitiveness of domestic firms.
Foreign Direct Investment (FDI) is often seen as a major
element in the host country’s industrial development and
growth
India is one of many developing countries that have started an
economic liberalization reform in the recent decade.
Promotion of FDI forms an integral part of India’s new
economic policies and the inflow of FDI has increased since it
started to liberalize its economy in the beginning of the 1990s.
3
4. TYPES OF FDI
Green field
investment
Brown field
investment
Joint Venture
4
5. IMPORTANCE OF FDI
FDI is often seen as a catalyst for a country’s development and
economic growth.
Foreign direct investment allows company to accomplish
several tasks:-
1. Integration into global economy.
2. Technology advancement.
3. Increased competition.
4. Improved human resources.
Reasons for the importance of FDI is not only the fact that the
foreign investor finances the “hardware” such as investment in
new plants and equipment, but FDI can be a major transfer of
technology, knowledge and capital for the host industries. With
FDI comes financial and managerial resources, access to
larger markets, technical assistance and strategic assets, for
instance; Brand name, which can give the host firms, domestic
and international, comparative advantage.
5
6. Inflation may increase.
Domestic firms may suffer if they are
relatively uncompetitive
If there is a lot of FDI into one industry e.g.
the automotive industry then a country can
become too dependent on it and it may
turn into a risk
That is the real danger of the 100 per cent
FDI and the selling/takeover of Indian
companies
DISADVANTAGES OF FDI
6
7. FDI IN INDIA
The policy initiative taken by the government of India in the 1990s
helped to transform the country from a restrictive regime with regard
to foreign direct investment to a liberal one.
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
Sectors attracting highest FDI inflow
7
8. Factors attracting FDI in India:-
Apart from this, India’s huge market base and fast-
developing spending habits of middle-
class, favorable business environment, good
administrative setup, attractive foreign
policies, available, abundant skilled workforce, and
attractive incentives for investors, have contributed
to India becoming one of the preferred destinations
for investors.
Furthermore, India has an advantage over other
countries, including China, in terms of being an ideal
destination for investments, mainly due to its vibrant
democratic setup, a broad legal framework and
independent judicial system.
8
9. THE INDIAN PHARMACEUTICAL INDUSTRY
India is one of the few developing countries with a large
production base in pharmaceutical products. India’s trade in
pharmaceutical products has increased a lot since the
liberalization reforms and it has comparative advantages in
trade with pharmaceutical products, both bulk drugs and
formulations.
The Indian pharmaceutical industry ranks very high among
developing countries, in terms of technology and quality, and is
today in the front rank of India’s science based industries
9
10. FDI IN INDIAN PHARMACEUTICAL SECTOR
The inflow of FDI into India has increased a great deal in the last
fifteen years. The pharmaceutical industry attracted 2.11 % of
total FDI inflows during these years. In diagram we can see the
industries that attract most FDI in India. The pharmaceutical
industry was the 8th largest sector attracting FDI inflows
factors such as; skilled/ semi-skilled labor, well- developed local
supply chains, well-functioning infrastructure and knowledge
producing institutions are important for a firm to consider. Some
of these factors are reasons why pharmaceutical multinationals
have invested in India.
10
11. India’s large population and wide disease
pattern make the country attractive for
pharmaceutical firms.
Relatively cheap manpower and skilled labor
are other factors that attract foreign investors.
India has an exceptional advantage in
pharmaceuticals due to its good human
resources and highly skilled work force. English is
widely spoken, which makes communication
easy for foreign investors.
The production of pharmaceuticals is also
relatively cheap in India and there is a strong
production base in the country.
11
12. FDI Inflow in Indian Pharmaceutical
Industry
100% foreign direct investment (FDI) is allowed
under automatic route in the drugs and
pharmaceuticals sector, including those involving
use of recombinant technology.
Also, FDI up to 100% is permitted for brownfield
investments in the pharmaceuticals sector, under
the Government approval route. The drugs and
pharmaceuticals industry attracted foreign direct
investment to the tune of US$ 9.17 bn for the period
between April 2000 and January 2012.
12
13. 48.4 90.7 52.3 60.7
341.4 116.3 216.1 72 213
513
3208
9170
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
Recently the government released a comprehensive FDI policy
document effective from 1 April 2010, consolidating all prior policies and
regulations on FDI which are contained in FEMA, RBI Regulations and
press notes, press releases and clarifications, into one document. THIS
LEAD TO SUDDEN INCREASE IN FDI INLOW IN INDIAN PHARMA SECTOR
AFTER 2010 YEAR.
13
14. Conclusion
Pharmaceutical industry plays a very
crucial role in implementing the welfare
state of the people.
Economic growth of the industry along
with the availability of generic goods
and healthy competition is the need of
the hour for India.
After analyzing the impact of the FDI in
the Indian pharmaceutical industry, it is
established that India needs adequate
FDI and its spillovers for the growth of
the industry 14